February 15, 2017 / 6:16 AM / in 8 months

BRIEF-Navamedic Q4 EBITDA swings to profit of NOK 5.7 million

Feb 15 (Reuters) - Navamedic ASA:

* Q4 revenue 81.6 million Norwegian crowns ($9.7 million)versus 65.4 million crowns year ago

* Q4 EBITDA profit 5.7 million crowns versus loss 0.1 million crowns year ago

* Is preparing to introduce Sippi in U.S., which is currently scheduled for late 2017

* Says is also leveraging on its solid partnership with Topridge Pharma on plans for a future introduction of Sippi in China Source text for Eikon:

Further company coverage: ($1 = 8.3930 Norwegian crowns) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below